블로그

• Cardiovascular, cancer, and infection risks of Janus kinase inhibitors in rheumatoid arthritis ... assessed cardiovascular, malignancy, and serious infection risks associated with JAKi use compared to tumor necrosis factor inhibitor (TNFi) use, which served as the active comparator, in patients with rheumatoid blog.naver.com · 2025.06.16